A61K 39/102
Pasteurellales
Official title: {Pasteurellales, e.g. Actinobacillus}, Pasteurella; Haemophilus
A61K39/102 (Pasteurellales) appears on 446 US grants and 510 published applications in this corpus.
Search patents in A61K- Granted patents
- 446
- Published applications
- 510
- Assignees
- 265
- Inventors
- 838
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 3 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 6 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 7 | 0 |
| 1997 | 6 | 0 |
| 1998 | 12 | 0 |
| 1999 | 10 | 0 |
| 2000 | 10 | 0 |
| 2001 | 10 | 1 |
| 2002 | 11 | 14 |
| 2003 | 5 | 16 |
| 2004 | 13 | 15 |
| 2005 | 5 | 14 |
| 2006 | 11 | 24 |
| 2007 | 7 | 17 |
| 2008 | 8 | 26 |
| 2009 | 11 | 35 |
| 2010 | 17 | 25 |
| 2011 | 8 | 25 |
| 2012 | 8 | 25 |
| 2013 | 12 | 22 |
| 2014 | 25 | 34 |
| 2015 | 21 | 31 |
| 2016 | 28 | 32 |
| 2017 | 28 | 31 |
| 2018 | 27 | 18 |
| 2019 | 16 | 20 |
| 2020 | 15 | 18 |
| 2021 | 15 | 11 |
| 2022 | 9 | 21 |
| 2023 | 10 | 12 |
| 2024 | 8 | 8 |
| 2025 | 11 | 12 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Vaccine against Heamophilus parasuis1 Sep 2026US 12,721,885 B2Intervet Inc.
- Dosage and administration of a bacterial saccharide glycoconjugate vaccine27 Jan 2026US 12,533,418 B2Glaxosmithkline Biologicals SA
- Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof28 Oct 2025US 12,453,764 B2
- DNABII vaccines and antibodies with enhanced activity23 Sep 2025US 12,419,944 B2Research Institute At Nationwide Children's Hospital
- Immunogenic antigens9 Sep 2025US 12,409,214 B2Longhorn Vaccines and Diagnostics, LLC
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- Topical nasal pharmaceutical composition for the treatment and prophylaxis of chronic rhinosinusitis (crs)23 Apr 2026US 2026/0108489 A1
- Method for the purification of capsular polysaccharides16 Apr 2026US 2026/0102479 A1Biological E Limited
- Lipopolysaccharide (lps) deficient acinetobacter baumannii multivalent vaccine9 Oct 2025US 2025/0312434 A1
- Immunogenic compositions and methods for reducing transmission of pathogens2 Oct 2025US 2025/0302937 A1St. Jude Children?S Research Hospital
Most cited
By later US patents
- Immunogenic conjugates154US 4,673,574 A1987
- Immunogenic conjugates93US 4,902,506 AUniversity of Rochester · 1990
- Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response90US 6,797,276 B1The United States of America as represented by the Secretary of the Army · 2004
- Vaccine compositions and method for induction of mucosal immune response via systemic vaccination73US 5,518,725 AUniversity of Utah Research Foundation · 1996
- Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine70US 4,496,538 AConnaught Laboratories Limited · 1985